Stuart Hinchen

Co-Founder & CEO at QuVa Pharma

An active leader in the pharmaceutical marketplace for more than 20 years, Stuart co-founded QuVa Pharma in 2015 with long-standing business partner Peter Jenkins. Under their leadership, QuVa has experienced consistent year-over-year growth and is still rapidly expanding.

Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Stuart served as President and COO from 2007-2010 and CEO from 2011-2014. He was instrumental in establishing JHP as a leading injectable pharmaceutical company in the United States before selling the business in 2014.

Previously, Stuart was President of Mayne Pharma Americas, a unit of Mayne that was focused on the manufacture, development, and sale of generic injectable pharmaceuticals, primarily into the hospital market. He led the Americas activity through a period of significant growth and established Mayne Pharma USA as a stand-alone business, ultimately building the division into one of the leading generic oncology providers in the United States.


Org chart

Sign up to view 26 direct reports

Get started



Offices

This person is not in any offices